Filing Details
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) filed a Form 8-K with the Securities and Exchange Commission on July 30, 2026, disclosing a material event.
8k filedNASDAQ:TVGN
Tevogen Bio Holdings Inc. (TVGN) Reports Material Event to SEC
Filing Details Tevogen Bio Holdings Inc. (NASDAQ:TVGN) filed a Form 8-K with the Securities and Exchange Commission on July 30, 2026, disclosing a material event. Market Context…
Market Context
Tevogen Bio Holdings Inc.'s stock currently trades at $6.72 with a market capitalization of $85.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Tevogen Bio Holdings Inc.'s stock.
All SEC filings for Tevogen Bio Holdings Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TVGN Stock Page
Frequently Asked Questions
Where can I read TVGN's SEC filings?
Browse all filings on our TVGN SEC filings page.
What types of SEC filings does Tevogen Bio Holdings Inc. file?
Public companies like Tevogen Bio Holdings Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.